lundi 9 octobre 2017

Onco Actu du 9 octobre 2017

1. Biologie

DNA damage caused by cancer treatment reversed by ZATT protein [NIH]

State of immune system linked to worse survival in biliary tract cancers [Institute of Cancer Research]

3.1 Prévention - Tabac

Matt Myers: Philip Morris has a long history of funding what it calls independent research by previously credible researchers [The Cancer Letter]

How PR firms created “dialogue” structure used by cancer groups and tobacco clients [The Cancer Letter]

Former American Cancer Society CEO John Seffrin endorses cancer research venture funded by Philip Morris [The Cancer Letter]

3.2 Prévention - Obésité

Weight loss surgery linked to lower risk of cancer [Reuters]

4. Dépistage, diagnostic et pronostic

Could opticians refer patients with suspected brain tumours? [Cancer Research UK]

4.9 Dép., diag. & prono. - Sein

Gene test 'narrows down breast cancer risk' [BBC News]

Test for breast cancer risk could reduce pre-emptive mastectomies [The Guardian]

5.10 Traitements - Essais

Lilly MONARCH 3 Study Published in Journal of Clinical Oncology Demonstrates Benefit of Verzenio™ (abemaciclib) Plus NSAI in Advanced Breast Cancer [Lilly]

5.12.2 Immunothérapies - CAR-T

What is the hottest CAR cell therapy target beyond CD19? [Cell Trials]

5.12.3 Immunothérapies-combinaisons

Merck Hedges Bets With Keytruda Lung Study [Forbes]

‘Going big’: Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo [EndPoints]

5.2 Pharma

The European Medicines Agency accepts marketing authorisation application for Imfinzi in locally-advanced unresectable non-small cell lung cancer [AstraZeneca]

5.3 Traitements - FDA, EMA, NICE...

EMA Preps for Staff Shortages, Possible 'Major' Budget Deficit [RAPS]

FDA awards 15 grants for clinical trials to stimulate product development for rare diseases [FDA]

Facing an exodus, EMA starts to line up temp replacements as top staffers jump ship [EndPoints]

6. Lutte contre les cancers

Global Health: As Cancer Tears Through Africa, Drug Makers Draw Up a Battle Plan [NY Times]

6.11 Patients

The cancer stories no one wants to hear [STAT]

6.6 Publications

Publishers take ResearchGate to court, alleging massive copyright infringement [Science]